Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Monoclonal
  • CTLA-4 Antigen
  • Melanoma
  • Skin Neoplasms
  • Uveal Neoplasms

abstract

  • In this multicenter, retrospective analysis of 4 hospitals in the United States and Europe of patients with uveal melanoma, durable responses to ipilimumab and manageable toxicity were observed.

publication date

  • October 15, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3986037

Digital Object Identifier (DOI)

  • 10.1002/cncr.28282

PubMed ID

  • 23913718

Additional Document Info

start page

  • 3687

end page

  • 95

volume

  • 119

number

  • 20